BeStock  
Stocks › Biotechnology › PRAX

Praxis Precision Medicines PRAX

US equityMarket cap rank #1557Biotechnology
$300.43 −$10.47 (-3.37%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $300.43 0.00%
Open$310.07
Prev close$310.90
Day range$298.54 – $314.15
Volume806.2K
Market cap$8.40B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±5.6%last 12 reports
Closed higher6 of 1250% of the time
Best reaction+19.9%
Worst reaction-8.5%

Stock move on the day after each report

+2.6%2020/Q4+1.2%2021/Q3-1.7%2021/Q4-8.5%2022/Q1-7.4%2024/Q1+0.8%2024/Q2-1.2%2024/Q3-5.5%2025/Q2+0.8%2025/Q4-1.4%2026/Q1+16.0%2026/Q2+19.9%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q39 Nov 2026Pre Market±16.8%+19.94%Bigger than priced
2026/Q26 Aug 2026Pre Market±9.8%+15.95%Bigger than priced
2026/Q17 May 2026Pre Market±11.2%-1.42%Within range
2025/Q419 Feb 2026Pre Market±7.3%+0.81%Within range
2025/Q24 Aug 2025Pre Market±37.2%-5.55%Within range
2024/Q36 Nov 2024Pre Market±23.1%-1.18%Within range
2024/Q213 Aug 2024Pre Market±22.0%+0.81%Within range
2024/Q113 May 2024Pre Market±16.4%-7.36%Within range
2022/Q19 May 2022None±26.7%-8.54%Within range
2021/Q428 Feb 2022None–-1.73%–
2021/Q33 Nov 2021None±15.9%+1.24%Within range
2020/Q417 Mar 2021None–+2.56%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$106.91M-36.4% YoY
Net profit-$94.23M-27.5% YoY
Diluted EPS-$3.23+3.9% YoY
Free cash flow-$82.52M-26.8% YoY
Operating cash flow-$81.74M

Revenue, last 8 quarters

$7.5MDec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-58.7MDec '24$-69.3MMar '25$-71.1MJun '25$-73.9MSep '25$-88.9MDec '25$-92.6MMar '26$-83.7MJun '26$-94.2MSep '26

Profitability & balance sheet

Return on equity-44.8%
Return on assets-42.1%
Return on invested capital-44.8%
Current ratio14.53
Liabilities / assets4.0%
Cash & investments$745.32M
Net cash (debt)$745.32M

Discussion

No comments yet — be the first to weigh in on PRAX.

Sign in to join the discussion.

Scroll to Top